. 16k protein microarray design. The array is sub-divided into 48 blocks, each containing 676 spots. Protein spots are printed in duplicate. As positive control crude E. coli lysate (0.3, 0.4, and 0.5 mg mL −1 ) and as negative control elution buffer was spotted onto the slides. Control spots are randomly distributed over the whole array. In total, 281 positive and 82 negative control spots are printed onto the 16k microarray.
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Figure S2. SDS-PAGE (NuPAGE Novex, 4%-12% Bis-tris) of 2 µg UniPEx protein eluates (lanes 1-16) after Ni-NTA purification. PageRuler™ Plus Prestained Protein Ladder (Life Technologies, Carlsbad, CA, USA) was used. Figure S3 . Boxplot representing intra-experiment and inter-experiment coefficient of variation (CV) values of all proteins on the 16k microarray. Each box represents a replicate of a specimen (s1, s2, s3) which was processed on the microarray in triplicates on the same day (day1 and day2 = intra-experiment comparison) and on consecutive days (day1+2= inter-experiment comparison). Figure S4 . Overlaps of significant antigens derived from class comparison analysis with different data pre-processing methods (DWD, ComBat, quantile normalization, unnormalized) including the whole data set with all lung cancer cases versus controls ("All (r1-6)"), and "single-run" as well as "cross-run" analyses of the four histologic entities. Right upper half shows relative overlaps (%) and left lower half shows absolute overlaps. QNORM = quantile normalization, SCLC = small cell lung cancer, SqLC = squamous cell lung cancer, LCLC = large cell lung cancer, AdCa = adenocarcinoma of the lung, r = experimental run. Figure S5 . Overlaps of significant antigens derived from class comparison analysis (p < 0.001) with different data pre-processing methods (DWD, QN = quantile normalization, unnormalized, ComBat) for "single-run" analysis (run1 only to run4 only) and "cross-run" analysis (run1+5 to run4+6) for distinct histologic entities of lung cancer (SCLC = small cell lung cancer, SqLC = squamous cell lung cancer, LCLC = large cell lung cancer, AdCa = adenocarcinoma of the lung), as well as for all cases versus all controls including all samples. Table S1 . Classifier list established with class prediction using quantile normalized data and 100 recursive feature elimination using all cases (n = 100) versus all controls (n = 100). For class prediction results compare Table S2 . Classifier list established with class prediction using ComBat-adjusted data and 25 greedy pairs using all cases (n = 100) versus all controls (n = 100). For class prediction results compare 
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